MedPath logo

ZYMAR OPHTHALMIC SOLUTION 0.3%

Prescription Only
Drug type: Therapeutic
ATC code: S01AX21
Dosage form: SOLUTION
Route of administration: OPHTHALMIC
Active ingredient: GATIFLOXACIN; GATIFLOXACIN

INDICATIONS AND USAGE

ZYMAR® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:

Aerobic Gram-Positive Bacteria:_Cornyebacterium propinquum*__Streptococcus mitis*_Staphylococcus aureus__Streptococcus pneumoniae__Staphylococcus epidermidis

Aerobic Gram-Negative Bacteria:Haemophilus influenzae

\* Efficacy for this organism was studied in fewer than 10 infections.

CONTRAINDICATIONS

ZYMAR® solution is contraindicated in patients with a history of hypersensitivity to gatifloxacin, to other quinolones, or to any of the components in this medication.

DOSAGE AND ADMINISTRATION

The recommended dosage regimen for the treatment of bacterial conjunctivitis is:

Days 1 and 2: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times daily.

Days 3 through 7: Instill one drop up to four times daily while awake.

Registrant
ABBVIE PTE. LTD.
Approval Date
2004-11-05
Approval Number
SIN12612P
Manufacturer
ALLERGAN SALES LLC
Licence Holder
ABBVIE PTE. LTD.